Considerations for DPIs and MDIs in Inhalation Drug Delivery

barmalini/Adobe.Stock.com

In inhalation drug delivery, various milling and micronization processes have been used to manufacture particles for dry powder inhaler (DPI) and metered dose inhaler (MDI) drug–device combination products. The trend today, however, is an increasing use of engineered particles, such as those made by spray drying for DPI applications. Pharmaceutical Techology spoke with Carolyn Berg, vice-president, Inhalation and Carla Vozone, vice-president, Inhalation Strategy, Innovation, and Partnerships, at Catalent; Robin Heath, head of new product innovation and commercial management, and Peter Hirst, commercial vice-president, at Recipharm; and Sandy Munro, senior vice-president, pharmaceutical development, at Vectura. These contract development and manufacturing organization (CDMO) experts shared their perspective on trends and considerations for choosing and designing a drug delivery device.

Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.

Article Details

Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 36–42

Citation

When referring to this article, please cite it as J. Markarian, “Considerations for DPIs and MDIs in Inhalation Drug Delivery,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).